Global Biotechnology Instruments Market To Reach $98.14 Billion By 2028 With A Growth Rate Of 6.7%

December 06, 2024 10:30 AM AEDT | By EIN Presswire
 Global Biotechnology Instruments Market To Reach $98.14 Billion By 2028 With A Growth Rate Of 6.7%
Image source: EIN Presswire

LONDON, GREATER LONDON, UNITED KINGDOM, December 6, 2024 /EINPresswire.com/ -- The Business Research Company’s Early Year-End Sale! Get up to 30% off detailed market research reports—limited time only!

What Does Historical Data Say About The Biotechnology Instruments Market Growth?

In the recent years, the biotechnology instruments market has shown substantial growth. It will grow from $71.06 billion in 2023 to $75.64 billion in 2024 at a compound annual growth rate CAGR of 6.4%. Factors contributing to this growth in the historic period include increased complications from chronic diseases, growing focus on digital solutions, an expanding geriatric population, rising demand for reverse transcription polymerase chain reaction RT-PCR tests, and increasing trends of miniaturization.

Get a glimpse of the complete report with our sample: https://www.thebusinessresearchcompany.com/sample.aspx?id=19338&type=smp

How Will The Biotechnology Instruments Market Perform In The Near Future?

The biotechnology instruments market is expected to keep its growth momentum in the next few years. It will reach a staggering worth of $98.14 billion in 2028 at a compound annual growth rate CAGR of 6.7%. This growth is foreseeable due to several factors including increasing biotechnology research, rising global healthcare expenses, lost productivity, growth in the applications of medical lasers, the need for development of novel vaccines, drugs, therapies, and diagnostic devices, and the burden of target diseases.

What Are The Key Drivers Of The Biotech Market?

Furthermore, the prevalence of chronic diseases is expected to significantly drive the growth of the biotechnology instruments market going forward. Chronic diseases are long-term health conditions—typically persisting for three months or longer—that mainly occur due to unhealthy lifestyle choices, an aging population, and increased awareness and diagnosis.

Biotechnology instruments are escalating the quality of life for patients with chronic diseases by enhancing diagnostics, optimizing treatments, and facilitating better disease management. They play a key role in identifying potential drug candidates and enlightening their effects on chronic diseases.

Pre-book the report for a swift delivery:
https://www.thebusinessresearchcompany.com/report/biotechnology-instruments-global-market-report

Who Are The Major Players In The Biotechnology Instruments Market?

Prominent companies operating in the biotechnology instruments market include Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Merck KGaA, Quest Diagnostics Inc., Avantor Inc., Agilent Technologies, Illumina Inc., Sartorius AG, Mettler Toledo, Perkin Elmer Inc., Shimadzu Corporation, Bruker Corporation, Zeiss Group, QIAGEN N.V., Novanta Inc., Cynosure LLC, Bio-Rad Laboratories Inc., Ori Biotech Limited, and Hudson Robotics.

What Are The Latest Trends In The Biotech Instrument Market?

Innovation is key in this market, with leading companies focusing on developing cutting-edge products like single-cell multi-omics products, which could revolutionize personalized medicine and advance genomics, proteomics, and metabolomics research.

How Is The Biotech Instruments Market Segmented?

The biotechnology instruments market report includes segmentation:

1 By Product: Lab Automation Instruments, Life Science Consumables, In Vitro Diagnostic IVD Instruments
2 By Application: Clinical Diagnostics, Drug Discovery And Development, Proteomics And genomics, Cell Analysis, Other Applications
3 By End-user: Pharmaceutical And Biotechnology Companies, Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Other End Users

What Are The Regional Insights Into The Biotech Instruments Market?

North America held the most substantial share in the biotechnology instruments market in 2023. However, Asia-Pacific is predicted to be the fastest-growing region during the forecast period.

Browse more similar reports-
Biotechnology Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/biotechnology-services-global-market-report
Biotechnology Reagents Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/biotechnology-reagents-global-market-report
Animal Biotechnology Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/animal-biotechnology-global-market-report


About The Business Research Company:
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/](https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company](https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ](https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model](https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
X
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.